Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient

Journal of Clinical Rheumatology

Volumn 17, Issue 2, 2011, Pages 73-75

  Ayub, Asad ^a   Kenney, Charles V ^b   McKiernan, Fergus E ^b  

^a Memorial Hospital Jacksonville   (United States)

^b MARSHFIELD CLINIC   (United States)

Author keywords

periostitis; voriconazole

Indexed keywords

ANALGESIC AGENT; CALCITRIOL; GLUCOCORTICOID; VORICONAZOLE;

AGED; ARM SWELLING; ARTICLE; BONE SCINTISCANNING; CASE REPORT; FEMALE; GRAFT RECIPIENT; HUMAN; HYPERPARATHYROIDISM; LUNG TRANSPLANTATION; MULTIFOCAL NODULAR PERIOSTITIS; PERIOSTITIS; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; X RAY FILM;

AGED; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; OPPORTUNISTIC INFECTIONS; PERIOSTITIS; PULMONARY ASPERGILLOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PYRIMIDINES; TRIAZOLES;

EID: 79952439619     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31820aff12     Document Type: Article

References (12)

1. Wang TF, Wang T, Altman R, et al. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients. Am J Transplant. 2009;9:2845-2850.
2. Chen L, Mulligan ME. Medication-induced periostitis in lung transplantpatients: periostitis deformans revisited. Skeletal Radiol. 2010; 22 DOI: 10.1007/s00256-010-0997-y. Accessed October 4, 2010.
3. Dickinson CJ. The aetiology ofclubbing and hypertrophic osteoarthropathy. Eur J Clin invest. 1993;23:330-338.
4. Soriano M. Periostitis deformans. Ann Rheum Dis. 1952;11:154-161.
5. Soriano M, Manchon F. Radiologic aspects of a new type ofbone fluorosis, periostitis deformans. Radiology. 1966;87:1089-1094.
6. Uppal S, Diggle CP, Carr IM, et al. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet. 2008;40:789-793. (Pubitemid 351748871)
7. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pccompound& term=voriconazole. Accessed October 3, 2010.
8. Klemmer PJ, Hadler NM. Subacute fluorosis, a consequence ofabuse of an organofluoride anesthetic. Ann Intern Med. 1978;89:607-611. (Pubitemid 9060010)
9. Meunier PJ, Courpron P, Smoller JS, et al. Niflumic acid-induced skeletal fluorosis, iatrogenic disease or therapeutic perspective for osteoporosis. Clin Orthop Relat Res. 1980;148:304-309. (Pubitemid 11243099)
10. Riggs BL, O'Fallon WM, Lane A, et al. Clinical trial offluoride therapy in postmenopausal osteoporotic women, extended observations and additional analysis. JBone Min Res. 1994;9:265-275. (Pubitemid 24041572)
11. Rich C, Ensinck J, Ivanovich P. The effects ofsodium fluoride on calcium metabolism ofsubjects with metabolic bone disease. J Clin Invest. 1964;43:545-556.
12. Hurrell DJ. The nerve supply ofbone. JAnat. 1937;72:54-61.